Skip to main content

Finance & Markets

Bambusa Therapeutics Files for IPO to Fund Eczema Drug Trials

Bambusa Therapeutics Inc. filed for a initial public offering to help fund trials of its drugs to treat eczema and other inflammation disorders.

bloomberg.com ·1h ago

We haven't written up this one. Bloomberg has the full story — the link below goes straight to it.

Read the original at bloomberg.com →

More in Finance & Markets

Kalshi probes suspicious trades tied to Trump press secretary pick, WSJ reports

1h ago ·investing.com

Mueller Water director Brian Healy buys $29,927 in stock

1h ago ·investing.com

PTC Therapeutics director Michael Schmertzler sells $158k in shares

1h ago ·investing.com

Elon Musk Just Made a Surprising Statement About AI Chips. Here's the Stock It Helps.

Key PointsElon Musk recently said that Space Exploration Technologies will only use Nvidia chips moving forward.

1h ago ·nasdaq.com

Ksh118.8B pension crisis: Senators push counties to pay retirees as new system targets arrears

County governments are under renewed pressure to settle Ksh118.8 billion in outstanding pension liabilities, as senators push for repayment plans and a new automatic deduction system seeks to prevent…

1h ago ·peopledaily.digital

Clean Air Metals closes C$150,000 private placement

1h ago ·investing.com

More from Friday 9 October →